Group C:traditional Chinese medicine treatment and Lopinavir / Ritonavir

2 trials

Sponsors

China Academy of Chinese Medical Sciences

Conditions

novel coronavirus pneumonia (COVID-19)

Early Phase 1

Clinical Controlled Trial for Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19)

RecruitingITMCTR2000002940

China Academy of Chinese Medical Sciencesnovel coronavirus pneumonia (COVID-19)

Start: 2020-01-29Updated: 2023-02-20

Clinical Controlled Trial for Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19)

RecruitingChiCTR2000029400

China Academy of Chinese Medical Sciencesnovel coronavirus pneumonia (COVID-19)

Start: 2020-01-29Updated: 2020-02-17